Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOPHOSPHAMIDE Cause Bladder cancer? 50 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Bladder cancer have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 0.0% of all adverse event reports for CYCLOPHOSPHAMIDE.

50
Reports of Bladder cancer with CYCLOPHOSPHAMIDE
0.0%
of all CYCLOPHOSPHAMIDE reports
10
Deaths
9
Hospitalizations

How Dangerous Is Bladder cancer From CYCLOPHOSPHAMIDE?

Of the 50 reports, 10 (20.0%) resulted in death, 9 (18.0%) required hospitalization, and 7 (14.0%) were considered life-threatening.

Is Bladder cancer Listed in the Official Label?

Yes, Bladder cancer is listed as a known adverse reaction in the official FDA drug label for CYCLOPHOSPHAMIDE.

What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?

Off label use (12,578) Febrile neutropenia (11,318) Drug ineffective (8,142) Neutropenia (7,352) Disease progression (7,100) Pyrexia (6,126) Product use in unapproved indication (5,750) Thrombocytopenia (4,669) Pneumonia (4,595) Nausea (4,561)

What Other Drugs Cause Bladder cancer?

RANITIDINE (41,984) PIOGLITAZONE (7,295) METFORMIN\PIOGLITAZONE (278) ADALIMUMAB (268) ETANERCEPT (225) METHOTREXATE (179) INFLIXIMAB (165) APIXABAN (159) VALSARTAN (144) LENALIDOMIDE (120)

Which CYCLOPHOSPHAMIDE Alternatives Have Lower Bladder cancer Risk?

CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE vs CYCLOSERINE CYCLOPHOSPHAMIDE vs CYCLOSPORINE

Related Pages

CYCLOPHOSPHAMIDE Full Profile All Bladder cancer Reports All Drugs Causing Bladder cancer CYCLOPHOSPHAMIDE Demographics